CIK 0001563880
- Non-accelerated filer
- Smaller reporting company
Trevi Therapeutics, Inc.
Sign in to watch- Ticker
- TRVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450834299
- Phone
- +1 203-304-2499
- Business address
- 195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $595,806
- in 1 filing, $596K under 10b5-1 plans
Net −$595,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 6 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-09 | Mellon Family Investment Co V 10% owner | Other acquisition | +24,340 | 247,156 | ||
| 2019-05-09 | Mellon Family Investment Co V 10% owner | Purchase | +100,000 | $10.00 | $1.0M | 347,156 |
| 2019-05-09 | Mellon Family Investment Co V 10% owner | Conversion · Series C Preferred Stock | −1,908,450 | 0 | ||
| 2019-05-09 | OSHEA WILLIAM J 10% owner | Conversion | +99,046 | 114,080 | ||
| 2019-05-09 | OSHEA WILLIAM J 10% owner | Conversion · Series A Preferred Stock | −307,607 | 0 | ||
| 2019-05-09 | OSHEA WILLIAM J 10% owner | Conversion · Series C Preferred Stock | −478,951 | 0 | ||
| 2019-05-09 | Heffernan Michael Thomas Director | Conversion | +3,851 | 3,851 | ||
| 2019-05-09 | Heffernan Michael Thomas Director | Purchase | +2,500 | $10.00 | $25K | 6,351 |
| 2019-05-09 | Heffernan Michael Thomas Director | Conversion · Series C Preferred Stock | −34,247 | 0 | ||
| 2019-05-09 | GOOD JENNIFER L | Conversion | +18,348 | 194,954 | ||
| 2019-05-09 | GOOD JENNIFER L | Purchase | +11,250 | $10.00 | $113K | 206,204 |
| 2019-05-09 | GOOD JENNIFER L | Conversion · Series A Preferred Stock | −109,015 | 0 | ||
| 2019-05-09 | GOOD JENNIFER L | Conversion · Series C Preferred Stock | −23,947 | 0 | ||
| 2019-05-09 | Aperture Venture Partners IV, L.P. 10% owner | Conversion | +232,963 | 232,963 | ||
| 2019-05-09 | Aperture Venture Partners IV, L.P. 10% owner | Purchase | +112,000 | $10.00 | $1.1M | 344,963 |
| 2019-05-09 | Aperture Venture Partners IV, L.P. 10% owner | Conversion · Series C Preferred Stock | −2,054,795 | 0 | ||
| 2019-05-09 | Agger Mette Kirstine Director | Conversion | +776,544 | 776,544 | ||
| 2019-05-09 | Agger Mette Kirstine Director | Purchase | +375,000 | $10.00 | $3.8M | 1,151,544 |
| 2019-05-09 | Agger Mette Kirstine Director | Conversion · Series C Preferred Stock | −6,849,315 | 0 | ||
| 2019-05-09 | Richard King Mellon Foundation 10% owner | Conversion | +222,816 | 222,816 |
Page 20 of 21 · 419 trades